Northwestern University Feinberg School of Medicine
Department of Medicine
Skip to main content

Division of Gastroenterology and Hepatology News

Read the latest news from Northwestern University Feinberg School of Medicine’s Department of Medicine, Division of Gastroenterology and Hepatology. The links below take you to articles where you can learn more about our faculty’s latest achievements, awards and honors.

  • 07.13.2018
    Researchers were able to establish an etiologic diagnosis among nearly 50% of patients with previously indeterminate etiology of acute liver failure using a systematic analysis strategy that included diagnostic algorithms and expert opinion.“Indeterminate or unknown etiology of acute liver failure is established after a careful history and a series of diagnostic blood tests are still unable to identify a clear cause for the serious liver injury,” Daniel R. Ganger, MD, from the Northwestern University Feinberg School of Medicine in Chicago, told Healio Gastroenterology and Liver Disease. According to Ganger and colleagues, indeterminate ALF etiology can also often result from incomplete testing or competing diagnoses
  • 06.29.2018

    Feinberg scientists are confronting significant, global challenges -- from antimicrobial resistance to HIV -- through collaborative, cutting-edge basic science and clinical research within the Division of Infectious Diseases.

  • 05.08.2018

    Northwestern faculty members have been chosen for induction into two prominent medical organizations: the American Society for Clinical Investigation and the Association of American Physicians.

  • 03.19.2018

    A new, shorter drug regimen to treat certain types of Hepatitis C was found to be as effective as the current, longer treatment, according to the findings of a large multi-center trial published in the New England Journal of Medicine.

  • 03.03.2018
    "University of Chicago Medicine and Northwestern Memorial Hospital, two of the five adult liver transplant centers in Illinois, recently changed their six-month-sober policies so that select people with acute alcoholic hepatitis — a small subset of people with alcoholic liver disease — can be considered for transplants without undergoing a set period of abstinence."
  • 02.18.2018
    "Listening to your gut is about more than responding to your body when you feel uneasy or need to make a decision."
  • 01.18.2018

    Northwestern Medicine Digestive Health Center Clinical Research Dietitian, Bethany Doerfler, MS, RDN, explains why you should bring mindfulness to your meals.

  • 01.17.2018

  • 01.05.2018

    "'The signs and symptoms are usually abdominal cramps, nausea with or without vomiting, and diarrhea,' says John Pandolfino, M.D., chief of gastroenterology and hepatology at Northwestern Memorial Hospital. This includes feeling weak and fatigued, and could also include fever and chills. It's not always 'exotic' foods that cause food poisoning. Often, it's caused by your food handler, a contaminated kitchen, or a contaminated source, like the fields where your food was grown."

  • 12.27.2017
    "She went into labor Christmas Day Morning and baby Autumn was born later that day at 5 o'clock at Northwestern Memorial Hospital.  She weighed 4 pounds 13 anounces. Her doctors say the success rate for a live birth with a liver transplant is between 65% to 75%.  The fact that Krystin also had a kidney transplant and had a healthy baby is considered remarkable."
  • 12.17.2017
    "Recently, an outbreak occurred at a New York state country club after an employee with the illness prepared food at the club’s restaurant, according to the Westchester County Department of Health. Plus, five more people were diagnosed with hepatitis A after being exposed to the virus by a sick employee at the restaurant Bartaco, in Port Chester, New York."
  • 01.09.2017

    Patients with hepatitis C virus infection who received an antiviral drug around the time they underwent liver transplantation saw a high rate of sustained virologic response, according to a Northwestern Medicine clinical trial.

  • 01.06.2017

    A drug called ustekinumab significantly improved symptoms for patients with moderate to severe Crohn’s disease, according to Northwestern Medicine clinical trials published in the New England Journal of Medicine.

Back to top